0001562180-24-005021.txt : 20240612 0001562180-24-005021.hdr.sgml : 20240612 20240612193257 ACCESSION NUMBER: 0001562180-24-005021 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240610 FILED AS OF DATE: 20240612 DATE AS OF CHANGE: 20240612 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Fox Jonathan C CENTRAL INDEX KEY: 0001655016 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40236 FILM NUMBER: 241039712 MAIL ADDRESS: STREET 1: C/O MYOKARDIA, INC. STREET 2: 333 ALLERTON AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Edgewise Therapeutics, Inc. CENTRAL INDEX KEY: 0001710072 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 821725586 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1715 38TH ST CITY: BOULDER STATE: CO ZIP: 80301 BUSINESS PHONE: 720-262-7002 MAIL ADDRESS: STREET 1: 1715 38TH ST CITY: BOULDER STATE: CO ZIP: 80301 4 1 primarydocument.xml PRIMARY DOCUMENT X0508 4 2024-06-10 false 0001710072 Edgewise Therapeutics, Inc. EWTX 0001655016 Fox Jonathan C C/O EDGEWISE THERAPEUTICS, INC. 1715 38TH STREET BOULDER CO 80301 true false false false false Stock Option (Right to Buy) 17.13 2024-06-10 4 A false 20594.00 0.00 A 2025-06-10 2034-06-10 Common Stock 20594.00 20594.00 D 100% of the Stock Options granted on June 10, 2024 will become vested on the earlier of (i) June 10, 2025 or (ii) the business day prior to the 2025 annual meeting of stockholders. /s/ John R. Moore, Attorney-in-Fact for Fox Jonathan C 2024-06-12